PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,878 | +34.9% | 29,296 | +37.6% | 0.00% | +33.3% |
| Q2 2023 | $133,313 | +31.4% | 21,296 | +0.1% | 0.00% | +50.0% |
| Q1 2023 | $101,487 | -45.2% | 21,276 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $185,102 | -27.1% | 21,276 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $254,000 | -9.9% | 21,276 | +7.6% | 0.01% | 0.0% |
| Q2 2022 | $282,000 | – | 19,782 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,309,397 | $2,121,223 | 1.51% |
| Sio Capital Management, LLC | 2,708,408 | $4,387,621 | 1.19% |
| Euclidean Capital LLC | 2,627,643 | $4,256,782 | 0.54% |
| Aldebaran Capital, LLC | 351,243 | $569,014 | 0.53% |
| Exome Asset Management LLC | 358,400 | $580,608 | 0.51% |
| Acuitas Investments, LLC | 353,749 | $573,073 | 0.31% |
| Orbimed Advisors | 6,475,291 | $10,489,971 | 0.21% |
| Ghost Tree Capital, LLC | 375,000 | $607,500 | 0.19% |
| Opaleye Management Inc. | 475,000 | $769,500 | 0.18% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $891,554 | 0.14% |